Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome

OBJECTIVE: To establish the clinical safe and effective methods of arsenic-containing compound-Qinghuang Powder (compound-QHP) in the treatment of myelodysplastic syndrome (MDS). METHODS: 200 patients with MDS were treated with compound-QHP (daily dose of 0.1 g realgar). The blood arsenic concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qianzhe, Deng, Zhongyang, Zhu, Shirong, Zhao, Pan, Wang, Mingjing, Hu, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733968/
https://www.ncbi.nlm.nih.gov/pubmed/29348764
http://dx.doi.org/10.1155/2017/2095682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733968/
https://www.ncbi.nlm.nih.gov/pubmed/29348764
http://dx.doi.org/10.1155/2017/2095682

Ejemplares similares